PhaseBio Pharmaceuticals

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

Bitcoin $62,070.81 +2.34%
Ethereum $2,412.48 -0.23%
BNB $554.14 +0.26%
Optimism $1.56 +0.95%
Arbitrum $0.54 +0.97%
Solana $136.35 -0.64%
Polygon $0.39 +2.70%
Cosmos $4.24 +1.23%
Avalanche $24.74 -0.43%

PhaseBio Pharmaceuticals

company

Exit Type

IPO

Exit Date

Oct 17, 2018

Exit parties in this round

Partner	Fund Round	Return Amount	Return Multiplier
National Institutes of Health	Grant	—	—	Detail
AstraZeneca	Series E	—	—	Detail
Catalysta Ventures	Series A	—	—	Detail